Mitchell Gold
Vorstandsvorsitzender bei ALPINE IMMUNE SCIENCES, INC.
Vermögen: 7 Mio $ am 30.04.2024
Aktive Positionen von Mitchell Gold
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALPINE IMMUNE SCIENCES, INC. | Vorstandsvorsitzender | 24.07.2017 | - |
Vorsitzender | 24.07.2017 | - | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | - | - |
Washington Biotechnology & Biomedical Association | Direktor/Vorstandsmitglied | - | - |
Prostate Cancer Institute | Direktor/Vorstandsmitglied | 23.07.2009 | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Direktor/Vorstandsmitglied | - | - |
Alpine Bioventures, GP, LLC
Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Gründer | - | - |
Private Equity Investor | - | - |
Karriereverlauf von Mitchell Gold
Ehemalige bekannte Positionen von Mitchell Gold
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Alpine Biosciences, Inc.
Alpine Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Alpine Biosciences, Inc. provided research and development of protocells for treatment of rare diseases and cancer. The company was headquartered in Seattle, WA. | Vorsitzender | 01.01.2012 | 01.01.2014 |
Gründer | 01.01.2012 | 01.01.2014 | |
DENDREON CORPORATION | Direktor/Vorstandsmitglied | 24.06.2011 | 26.02.2013 |
Vorstandsvorsitzender | 01.01.2003 | 01.01.2012 | |
Vorsitzender | 02.02.2012 | 05.06.2012 | |
Präsident | 01.06.2001 | 02.02.2012 | |
Data Critical Corp.
Data Critical Corp. Packaged SoftwareTechnology Services Data Critical Corp. manufactures and supports open personal information communications applications. The company is based in Bothell, WA. The company was founded by David E. Albert. Data Critical was acquired by GE Medical Systems, Inc. on September 25, 2001 for $67.35 million. | Vertrieb & Marketing | 01.04.2000 | 01.05.2001 |
░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Mitchell Gold
University of Wisconsin | Undergraduate Degree |
Rush Medical College | Graduate Degree |
Statistik
International
Vereinigte Staaten | 15 |
Kanada | 2 |
Operativ
Director/Board Member | 7 |
Chairman | 4 |
Chief Executive Officer | 3 |
Sektoral
Commercial Services | 5 |
Health Technology | 4 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ALPINE IMMUNE SCIENCES, INC. | Health Technology |
Private Unternehmen | 11 |
---|---|
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Washington Biotechnology & Biomedical Association | |
Data Critical Corp.
Data Critical Corp. Packaged SoftwareTechnology Services Data Critical Corp. manufactures and supports open personal information communications applications. The company is based in Bothell, WA. The company was founded by David E. Albert. Data Critical was acquired by GE Medical Systems, Inc. on September 25, 2001 for $67.35 million. | Technology Services |
Elixis, Inc.
Elixis, Inc. Packaged SoftwareTechnology Services Elixis, Inc. develops internet-based healthcare applications. The American company was founded by Mitchell H. Gold, Edward M. Boyle. Elixis was acquired by Data Critical Corp. on April 04, 2000 for $2.44 million. | Technology Services |
Prostate Cancer Institute | |
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Commercial Services |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
SillaJen Biotherapeutics, Inc.
SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Commercial Services |
Alpine Immune Sciences, Inc. /Old/
Alpine Immune Sciences, Inc. /Old/ BiotechnologyHealth Technology Alpine Immune Sciences, Inc. operates as a biotechnology company which develops cancer immunotherapy systems. The firm provides immunotherapy and immune synapse solutions. The company was founded by Ryan Swanson and Michael Kornacker in 2015 and is headquartered in Seattle, WA. | Health Technology |
Alpine Biosciences, Inc.
Alpine Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Alpine Biosciences, Inc. provided research and development of protocells for treatment of rare diseases and cancer. The company was headquartered in Seattle, WA. | Commercial Services |
Alpine Bioventures, GP, LLC
Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Finance |
- Börse
- Insiders
- Mitchell Gold
- Erfahrung